HCCI's research on insulin prices was mentioned in a CNBC report. From the article: "The Centers for Disease Control and Prevention estimates more than 30 million Americans have diabetes. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from 2012 to 2016 to $5,700 from $2,900, according to an analysis by the nonprofit Health Care Cost Institute. Eli L...
HCCI recently provided cost information for iron infusions for an NPR article. From the article: "An analysis of private insurance claims conducted by the Health Care Cost Institute, an independent research group funded by insurers, found that in 2017, private health plans paid $4,316 per visit, on average, if a patient received Injectafer infusions. Feraheme, the next most expensive in...
Changes in opioid utilization correlated with state-level policy changes aimed at decreasing opioid prescription rates. Previous research by HCCI illustrated that national opioid utilization in pills per person fell 27% between the years of 2008 and 2017, driven by declines in the use of hydrocodone (Vicodin). In addition to giving insight into prescription opioid utilization by the commercially i...
HCCI's report with the New York State Health Foundation on health care spending in New York was recently featured in a Wall Street Journal article. From the article: "Health-care spending on New Yorkers who get insurance through work is higher and rising more sharply than the national average. The main reason, according to a new report, is price growth. Rising prices of doctor visits, i...
Spending per person in employer-sponsored plans reaches all-time high of $6,335 Health care spending for the average New Yorker with employer-sponsored health insurance is increasing faster in New York State than the rest of the country, according to a new analysis released today by the New York State Health Foundation (NYSHealth) and the Health Care Cost Institute (HCCI). Per-person spending grew...
